Outcome
    Strong Evidence
    Effectiveness 4/5

    Ashwagandha for Cortisol Reduction

    Ashwagandha is the best-evidenced supplement for lowering measured cortisol and perceived stress.

    Overview

    Ashwagandha has more direct biomarker evidence than most adaptogens. Randomised placebo-controlled trials using standardised root extracts have repeatedly measured serum cortisol as an endpoint and found reductions of roughly 15-30% over 8 to 12 weeks in chronically stressed adults, alongside improvements in perceived stress and anxiety scales. Two caveats shape how to read that. The trials are small — usually 50 to 130 participants — and a substantial proportion come from a handful of Indian research groups, sometimes with manufacturer involvement. And a falling cortisol number is a biomarker, not a clinical outcome; it is best interpreted alongside the symptom scales that moved with it.

    Verdict

    Strong yes

    Multiple randomised placebo-controlled trials show 15-30% reductions in serum cortisol with standardised root extracts at 300-600 mg daily, with parallel improvements in perceived stress. Trials are small and industry involvement is common.

    How It Works

    Withanolides, the active glycosides in Withania somnifera root, appear to act on the hypothalamic-pituitary-adrenal axis at multiple points. Animal and mechanistic work shows dampened corticotropin-releasing hormone signalling and reduced adrenal cortisol output in response to stressors, without the suppression seen with exogenous steroids. A parallel route runs through GABAergic signalling: withanolides have GABA-mimetic activity at GABA-A receptors, which plausibly explains the anxiolytic and sleep effects reported alongside cortisol change. Antioxidant and anti-inflammatory actions in the adrenal cortex may protect steroidogenic tissue from chronic stress load, though this is less firmly established.

    Pathways involved

    HPA axis modulation
    Reduced corticotropin-releasing hormone signalling
    Lower adrenal cortisol output
    GABA-A receptor mimetic activity
    Antioxidant protection of adrenal tissue
    Anti-inflammatory signalling

    Dosing & Protocol

    ScenarioDoseFormTiming
    Standard trial dose300 mg twice dailyStandardised root extract (KSM-66 or Sensoril)With meals
    Lower / starting dose300 mg once dailyStandardised root extractMorning or evening with food
    Higher trial dose600 mg twice dailyStandardised root extractShort-term trial use only
    Sleep-oriented use300 mgStandardised root extractEvening
    1. 1

      Pick a standardised root extract· Before starting

      Trials used named extracts standardised to withanolide content, typically 2.5-5%. Unstandardised whole-root powder was not what was tested.

    2. 2

      Start at 300 mg daily with food· Week 1

      Take with a meal to reduce the gastrointestinal upset that is the most common reason for stopping.

    3. 3

      Build to 600 mg daily if tolerated· Weeks 2-8

      Split into two doses, morning and evening — the regimen most trials used.

    4. 4

      Judge it at 8-12 weeks· Week 8-12

      Cortisol changes in trials emerged over eight weeks or more. Use a validated perceived stress measure alongside any lab test.

    5. 5

      Review long-term use· Month 3+

      Most trials ran 8 to 12 weeks. Beyond that the safety and efficacy data thin out considerably; periodic reassessment is sensible.

    Extract identity matters more than dose

    Withanolide content varies enormously between products, and root extract is not interchangeable with leaf or whole-plant material. Match the named, standardised extract used in trials rather than comparing milligram numbers on labels.

    Evidence

    The recurring finding across randomised placebo-controlled trials in chronically stressed adults is a serum cortisol reduction in the range of 15-30% after 8 to 12 weeks at 300-600 mg daily of standardised root extract, with parallel improvements on the Perceived Stress Scale and anxiety measures. Systematic reviews describe the direction of effect as consistent. Quality is the constraint. Sample sizes are small, several trials share sponsors or investigator groups, and publication bias is difficult to exclude in a literature this concentrated. Independent replication in larger, longer trials is the missing piece. No individual trials are linked to this pairing in our database yet, so this reflects the wider literature rather than pair-specific citations.
    Best available evidence
    Multiple small randomised placebo-controlled trials and systematic reviews
    Typical effect
    15-30% reduction in serum cortisol
    Studied dose
    300-600 mg daily standardised root extract
    Time to effect
    8-12 weeks
    Certainty of evidence
    Moderate, limited by trial size and sponsorship

    Safety

    Liver injury reports and pregnancy

    Rare cases of ashwagandha-associated liver injury have been reported, usually reversible on stopping. Stop and seek advice for jaundice, dark urine or unexplained fatigue. Ashwagandha is also traditionally abortifacient and should be avoided in pregnancy.

    Points to watch

    Gastrointestinal upset, nausea, loose stools
    Drowsiness
    Thyroid hormone elevation — caution in hyperthyroidism
    Autoimmune disease — may stimulate immune activity
    Rare hepatotoxicity

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    Thyroid hormone (levothyroxine)
    moderate
    		Ashwagandha can raise T3 and T4, risking over-replacementMonitor thyroid function; discuss before starting
    Sedatives and benzodiazepines
    moderate
    		Additive GABAergic sedationAvoid combining or use with caution
    Immunosuppressants
    high
    		Immune-stimulating activity may oppose the drugAvoid unless a specialist advises otherwise
    Antidiabetic and antihypertensive drugs
    low
    		Mild additive lowering of glucose and blood pressureMonitor readings when starting
    Hepatotoxic drugs and alcohol
    moderate
    		Additive liver burden given rare hepatotoxicity reportsLimit alcohol; report symptoms of liver injury

    References

    1. Chandrasekhar K et al. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012
    2. Salve J et al. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. Cureus. 2019

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.